Overview

Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Treatment with testosterone can improve performance on tests of spatial ability in men with low testosterone levels and Alzheimer's disease. Improved performance on these tests may mean an improved ability to get around in one's environment without getting lost or injured. This could have a positive impact on both patients and those who care for them. We will investigate what areas of the brain are involved in these improvements in spatial ability. This will be done using a PET scan, which creates a 3-dimensional image of the brain that can allow us to see how the brain functions.
Phase:
N/A
Details
Lead Sponsor:
Michael E. DeBakey VA Medical Center
VA Medical Center, Houston
Collaborator:
Solvay Pharmaceuticals
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate